Canadian guidelines for the management of dyslipidaemia

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.265, 2000-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dyslipidaemia treatment guidelines `are outdated'

Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Management of diabetic dyslipidaemia

Inpharma, Vol. 1, Iss. 1482, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

There is a smorgasbord of options in the management of dyslipidaemia in visceral obesity

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 8, 2005-08 ,pp. : 10-14

Adis International

Access to resources Recommend Favorite

Simvastatin plus ezetimibe: combination therapy for the management of dyslipidaemia

By Toth Peter P Davidson Michael H

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 131-139

Informa Healthcare

Access to resources Recommend Favorite

Micronised Fenofibrate: An Updated Review of its Clinical Efficacy in the Management of Dyslipidaemia

By Keating G.M. Ormrod D.

Drugs, Vol. 62, Iss. 13, 2002-01 ,pp. : 1909-1944

Adis International

Access to resources Recommend Favorite